2 months Scotiabank Forecasts Strong Price Appreciation for Agios Pharmaceuticals (NASDAQ:AGIO) Stock MarketBeat
Scotiabank lifted their price target on shares of Agios Pharmaceuticals from $51.00 to $53.00 and gave the stock a “sector outperform” rating in a report on Friday.
Nasdaq 100 · Pharmaceuticals · Scotiabank
X